Cancer continues to impact lives across the UK, and with no definitive cure in sight, early detection remains the best chance ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.

Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with ...

"Patients with stage III or IV kidney cancer are at high risk ... and therefore many possible neoantigens. But kidney cancer is a disease with fewer mutations, and therefore fewer targets to ...

Gazyva/Gazyvaro (obinutuzumab) was found to significantly improve complete renal response in lupus nephritis patients, ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...